Patient interview comments and HBV/HDV status before LT for the non-HBIg group
| Patient No. | Interview comments | HBV/HDV status before LT | Liver function at test (ALT/AST [IU/mL]) |
|---|---|---|---|
| 88 | NA regimen noncompliance during 2013–2016 | No information available | 45/40 |
| 74 | NA regimen noncompliance due to pregnancy in 2017 | No information available | 9.2/16.6 |
| 63 | NA regimen noncompliance in 2017 | No information available | 11.4/14.2 |
| 37 | NA regimen noncompliance due to an episode of toxic hepatitis in 2019 | HBV DNA, 6,830 IU/mL HDV RNA, not performed HCV RNA, <15 IU/mL |
489/183 |
| 2 | NA regiment noncompliance in 2021 | HBV DNA, 16,500 IU/mL HDV RNA, no information |
69/51 |
HBV, hepatitis B virus; HDV, hepatitis D virus; LT, liver transplant; HBIg, hepatitis B immunoglobulin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; NA, nucleos(t)ide analogue; HCV, hepatitis C virus.
a)Range, 0–40 IU/mL.